Sizhao Li, Wenli Li, Wei Jiang, Linrong He, Qinglin Peng, Guochun Wang, & Xin Lu. (2021). The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study. Frontiers Media S.A..
Chicago Style (17th ed.) CitationSizhao Li, Wenli Li, Wei Jiang, Linrong He, Qinglin Peng, Guochun Wang, and Xin Lu. The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationSizhao Li, et al. The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study. Frontiers Media S.A., 2021.
Warning: These citations may not always be 100% accurate.